Antibodies to human myeloperoxidase in glomerular immune deposits of systemic lupus erythematosus

Abstract

Antibodies to human myeloperoxidase and cathepsin G have been detected in the serum of some patients with systemic lupus erythematosus. Therefore, the presence of antibodies to human myeloperoxidase and cathepsin G was examined in glomerular immune deposits. Glomerular basement membrane fragments were prepared from renal tissues obtained at autopsy from 19 patients with systemic lupus erythematosus. IgG was extracted from the glomerular basement membrane fragments and tested with sensitive immunoassays for antibodies to myeloperoxidase and cathepsin G. Antibodies to cathepsin G were not detected in the extracts but antibodies to human myeloperoxidase were found in extracts of one specimen. In the extract with 6M guanidine hydrochloride these antibodies were enriched 103-fold, compared to the initial supernatant of glomeruli, which served as a serum surrogate. The recovered antibodies to myeloperoxidase accounted for 12% of the recovered IgG. These findings add autoantibodies to human myeloperoxidase to the list of antibodies that have been shown to be present in glomerular immune deposits of patients with lupus glomerulonephritis.

Keywords

lupus nephritis antibodies to myeloperoxidase systemic lupus erythematosus

Get full access to this article

View all access options for this article.

References

Koffler, D , Schur PH , Kunkel HG . Immunological studies concerning the nephritis of systemic lupus erythematosus . J Exp Med 1967; 126: 607–624 .

Mannik, M , Wener MH . Deposition of antibodies to the collagen-like region of C1q in renal glomeruli of patients with proliferative lupus glomerulonephritis . Arthritis Rheum 1997; 40: 1504–1511 .

Falk RJ , Jennette JC . Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis . New Engl J Med 1988; 318: 1651–1658 .

Kallenberg CGM , Brouwer E , Weening JJ , Cohen Tervaert JW . Antineutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential . Kidney Int 1994; 46: 1–15 .

Jennette JC , Falk RJ . Small-vessel vasculitis . New Engl J Med 1997; 337: 1513–1523 .

Cohen Tervaert JW , Goldschmeding R , Elema JD et al. Association of autoantibodies to myeloperoxidase with different forms of vascultitis . Arthritis Rheum 1990; 33: 1264–1272 .

Schnabel A , Csernok E , Isenberg DA et al. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus . Arthritis Rheum 1995; 38: 633–637 .

Uesugi H , Ozaki S , Sobajima J et al. Prevalence and characterization of novel pANCA, antibodies to the high mobility group non-histone chromosomal proteins HMG1 and HMG2, in systemic rheumatic diseases . J Rheumatol 1998; 25: 703–709 .

Zhao MH , Liu N , Zhang YK , Wang HY . Antineutrophil cytoplasmic autoantibodies (ANCA) and their target antigens in Chinese patients with lupus nephritis . Nephrol Dial Transplant 1998; 13: 2821–2824 .

10.

Minota S , Horie S , Yamada A et al. Circulating myeloperoxidase and anti-myeloperoxidase antibody in patients with vasculitis . Scand J Rheumatol 1999; 28: 94–99 .

11.

Nässberger L , Sjöholm AG , Jonsson H et al. Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus . Clin Exp Immunol 1990; 81: 380–383 .

12.

Küster S , Apenberg S , Andrassy K , Ritz E . Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus . Contrib Nephrol 1992; 99: 94–98 .

13.

Lee SS , Lawton JMW . Antimyeloperoxidase antibody in systemic lupus erythematosus . J Int Med 1992; 232: 283–284 .

14.

Cambridge G , Wallace H , Bernstein RM , Leaker B . Autoantibodies to myeloperoxidase in idiopathic and drug-induced systemic lupus erythematosus and vasculitis . Br J Rheumatol 1994; 33: 109–114 .

15.

Spronk PE , Bootsma H , Horst G et al. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus . Br J Rheumatol 1996; 35: 625–631 .

16.

Merkel PA , Polisson RP , Chang YC et al. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease . Ann Int Med 1997; 126: 866–873 .

17.

Nishiya K , Chikazawa H , Nishimura S et al. Anti-neutrophil cytoplasmic antibody in patients with systemic lupus erythematosus is unrelated to clinical features . Clin Rhematol 1997; 16: 70–75 .

18.

Galeazzi M , Morozzi G , Sebastiani F et al. Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. European concerted action on the immunogenetics of SLE . Clin Exp Rheumatol 1998; 16: 541–546 .

19.

Graham RC , Karnovsky MJ . Glomerular permeability: Ultrastructural cytochemical studies using peroxidases as protein tracers . J Exp Med 1966; 124: 1123–1134 .

20.

Camussi G , Tetta C , Segoloni G et al. Localization of neutrophil cationic proteins and loss of anionic charges in glomeruli of patients with systemic lupus erythematosus glomerulonephritis . Clin Immunol Immunopathol 1982; 24: 299–314 .

21.

Johnson RJ , Couser WG , Chi EY et al. New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxidase-halide system . J Clin Invest 1987; 79: 1379–1387 .

22.

Brouwer E , Huitema MG , Klok PA et al. Antimyeloperoxidaseassociated proliferative glomerulonephritis: an animal model . 1993; 177: 905–914 .

23.

Yang JJ , Jennette JC , Falk RJ . Immune complex glomerulonephritis is induced in rats immunized with heterologous myeloperoxidase . Clin Exp Immunol 1994; 97: 466–473 .

24.

Wener MH , Mannik M . Selective losses of large immune complexes during density gradient ultracentrifugation and an approach for prevention of these losses . J Immunol Meth 1985; 84: 1–10 .

25.

Amigo MC , Khamashta MA , Hughes GR . Antiphospholipid syndrome in SLE . Baillieres Clin Rheumatol 1998, 12: 477–493 .